Global Vaccines Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Vaccines Market
The global Vaccines market size is projected to reach US$ 62780 million by 2027, from US$ 42560 million in 2020, at a CAGR of 5.6% during 2021-2027.
Global Vaccines Scope and Segment
The global Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
By the end users/application, this report covers the following segments
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Competitive Landscape:
The report provides a list of all the key players in the Vaccines market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Vaccines key manufacturers in this market include:
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

TABLE OF CONTENT

1 Vaccines Market Overview
1.1 Vaccines Product Overview
1.2 Vaccines Market Segment by Type
1.2.1 Recombinant Vaccines
1.2.2 Viral Vaccines
1.2.3 Polysaccharide Vaccines
1.2.4 Others
1.3 Global Vaccines Market Size by Type
1.3.1 Global Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Vaccines Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Vaccines Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Vaccines Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Vaccines Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccines Sales Breakdown by Type (2016-2030)
1.4.2 Europe Vaccines Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Vaccines Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Vaccines Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Vaccines Sales Breakdown by Type (2016-2030)

2 Global Vaccines Market Competition by Company
2.1 Global Top Players by Vaccines Sales (2016-2030)
2.2 Global Top Players by Vaccines Revenue (2016-2030)
2.3 Global Top Players Vaccines Price (2016-2030)
2.4 Global Top Manufacturers Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccines Market Competitive Situation and Trends
2.5.1 Vaccines Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Vaccines Market
2.8 Key Manufacturers Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Vaccines Status and Outlook by Region
3.1 Global Vaccines Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Vaccines Historic Market Size by Region
3.2.1 Global Vaccines Sales in Volume by Region (2016-2030)
3.2.2 Global Vaccines Sales in Value by Region (2016-2030)
3.2.3 Global Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Vaccines Forecasted Market Size by Region
3.3.1 Global Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Vaccines by Application
4.1 Vaccines Market Segment by Application
4.1.1 Rabies vaccine
4.1.2 Influenza vaccine
4.1.3 HPV vaccine
4.1.4 Hepatitis B
4.1.5 Hepatitis A
4.1.6 Leprosy vaccine
4.1.7 Polio vaccine
4.1.8 JE vaccine
4.1.9 Others
4.2 Global Vaccines Market Size by Application
4.2.1 Global Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Vaccines Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Vaccines Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Vaccines Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Vaccines Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccines Sales Breakdown by Application (2016-2030)
4.3.2 Europe Vaccines Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Vaccines Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Vaccines Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Vaccines Sales Breakdown by Application (2016-2030)

5 North America Vaccines by Country
5.1 North America Vaccines Historic Market Size by Country
5.1.1 North America Vaccines Sales in Volume by Country (2016-2030)
5.1.2 North America Vaccines Sales in Value by Country (2016-2030)
5.2 North America Vaccines Forecasted Market Size by Country
5.2.1 North America Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Vaccines Sales in Value by Country (2022-2027)

6 Europe Vaccines by Country
6.1 Europe Vaccines Historic Market Size by Country
6.1.1 Europe Vaccines Sales in Volume by Country (2016-2030)
6.1.2 Europe Vaccines Sales in Value by Country (2016-2030)
6.2 Europe Vaccines Forecasted Market Size by Country
6.2.1 Europe Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Vaccines Sales in Value by Country (2022-2027)

7 Asia-Pacific Vaccines by Region
7.1 Asia-Pacific Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Vaccines Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Vaccines Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Vaccines Sales in Value by Region (2022-2027)

8 Latin America Vaccines by Country
8.1 Latin America Vaccines Historic Market Size by Country
8.1.1 Latin America Vaccines Sales in Volume by Country (2016-2030)
8.1.2 Latin America Vaccines Sales in Value by Country (2016-2030)
8.2 Latin America Vaccines Forecasted Market Size by Country
8.2.1 Latin America Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Vaccines Sales in Value by Country (2022-2027)

9 Middle East and Africa Vaccines by Country
9.1 Middle East and Africa Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Vaccines Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Vaccines Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Vaccines Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Vaccines Business
10.1 GSK
10.1.1 GSK Corporation Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.1.4 GSK Vaccines Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi
10.2.1 Sanofi Corporation Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Sanofi Vaccines Products Offered
10.2.5 Sanofi Recent Development
10.3 Merck
10.3.1 Merck Corporation Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Merck Vaccines Products Offered
10.3.5 Merck Recent Development
10.4 Pfizer
10.4.1 Pfizer Corporation Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Pfizer Vaccines Products Offered
10.4.5 Pfizer Recent Development
10.5 Novartis(GSK)
10.5.1 Novartis(GSK) Corporation Information
10.5.2 Novartis(GSK) Introduction and Business Overview
10.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Novartis(GSK) Vaccines Products Offered
10.5.5 Novartis(GSK) Recent Development
10.6 CSL
10.6.1 CSL Corporation Information
10.6.2 CSL Introduction and Business Overview
10.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.6.4 CSL Vaccines Products Offered
10.6.5 CSL Recent Development
10.7 MedImmune LLC
10.7.1 MedImmune LLC Corporation Information
10.7.2 MedImmune LLC Introduction and Business Overview
10.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.7.4 MedImmune LLC Vaccines Products Offered
10.7.5 MedImmune LLC Recent Development
10.8 J&J(Crucell)
10.8.1 J&J(Crucell) Corporation Information
10.8.2 J&J(Crucell) Introduction and Business Overview
10.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.8.4 J&J(Crucell) Vaccines Products Offered
10.8.5 J&J(Crucell) Recent Development
10.9 China National Biotec
10.9.1 China National Biotec Corporation Information
10.9.2 China National Biotec Introduction and Business Overview
10.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.9.4 China National Biotec Vaccines Products Offered
10.9.5 China National Biotec Recent Development
10.10 Tiantan
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Vaccines Product Category, Application and Specification
10.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Tiantan Recent Development
10.11 Hualan
10.11.1 Hualan Corporation Information
10.11.2 Hualan Introduction and Business Overview
10.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Hualan Vaccines Products Offered
10.11.5 Hualan Recent Development
10.12 Kangtai
10.12.1 Kangtai Corporation Information
10.12.2 Kangtai Introduction and Business Overview
10.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Kangtai Vaccines Products Offered
10.12.5 Kangtai Recent Development
10.13 Hissen
10.13.1 Hissen Corporation Information
10.13.2 Hissen Introduction and Business Overview
10.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.13.4 Hissen Vaccines Products Offered
10.13.5 Hissen Recent Development
10.14 Jintan
10.14.1 Jintan Corporation Information
10.14.2 Jintan Introduction and Business Overview
10.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.14.4 Jintan Vaccines Products Offered
10.14.5 Jintan Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccines Industrial Chain Analysis
11.4 Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccines Distributors
12.3 Vaccines Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample